Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

NCT02600364 is registered in ClinicalTrials.gov with Phenox GmbH as lead sponsor.

NCT NCT02600364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device
Lead sponsor
Phenox GmbH
Phase
Observational
Overall status
Completed
Start date
December 31, 2015
Completion date
June 30, 2020
Enrollment
450 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm